A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Kengo Takeuchi, Young Lim Choi, Manabu Soda, Kentaro Inamura, Yuki Togashi, Satoko Hatano, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Yukitoshi Satoh,[...]. Clin Cancer Res 2008
370
18

Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition.
Jenny Y Xue, Yulei Zhao, Jordan Aronowitz, Trang T Mai, Alberto Vides, Besnik Qeriqi, Dongsung Kim, Chuanchuan Li, Elisa de Stanchina, Linas Mazutis,[...]. Nature 2020
111
18

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
Jude Canon, Karen Rex, Anne Y Saiki, Christopher Mohr, Keegan Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G Knutson, Neelima Koppada,[...]. Nature 2019
537
18

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D Planchard, S Popat, K Kerr, S Novello, E F Smit, C Faivre-Finn, T S Mok, M Reck, P E Van Schil, M D Hellmann,[...]. Ann Oncol 2018
487
18

Label-Free Surface Protein Profiling of Extracellular Vesicles by an Electrokinetic Sensor.
Sara Cavallaro, Josef Horak, Petra Hååg, Dhanu Gupta, Christiane Stiller, Siddharth S Sahu, André Görgens, Hithesh K Gatty, Kristina Viktorsson, Samir El Andaloussi,[...]. ACS Sens 2019
22
18

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.
A K Krug, D Enderle, C Karlovich, T Priewasser, S Bentink, A Spiel, K Brinkmann, J Emenegger, D G Grimm, E Castellanos-Rizaldos,[...]. Ann Oncol 2018
83
18

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR.
Christiane Stiller, Kristina Viktorsson, Elizabeth Paz Gomero, Petra Hååg, Vasiliki Arapi, Vitaliy O Kaminskyy, Caroline Kamali, Luigi De Petris, Simon Ekman, Rolf Lewensohn,[...]. Cancers (Basel) 2021
3
66

Streaming potential studies of colloid, polyelectrolyte and protein deposition.
Z Adamczyk, K Sadlej, E Wajnryb, M Nattich, M L Ekiel-Jezewska, J Bławzdziewicz. Adv Colloid Interface Sci 2010
74
18

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer.
Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi, Seon Ye Kim, Jung-Eun Lee, Ki Jung Sung, Young Hoon Sung, Chan-Gi Pack, Min-Kyo Jung, Buhm Han,[...]. Exp Mol Med 2019
101
18

Electrokinetic effect for molecular recognition: A label-free approach for real-time biosensing.
Apurba Dev, Josef Horak, Andreas Kaiser, Xichen Yuan, Anna Perols, Per Björk, Amelie Eriksson Karlström, Pascal Kleimann, Jan Linnros. Biosens Bioelectron 2016
6
33


Electrokinetic sandwich assay and DNA mediated charge amplification for enhanced sensitivity and specificity.
Siddharth Sourabh Sahu, Christiane Stiller, Elizabeth Paz Gomero, Ábel Nagy, Amelie Eriksson Karlström, Jan Linnros, Apurba Dev. Biosens Bioelectron 2021
3
66

Liquid biopsy for lung cancer early detection.
Mariacarmela Santarpia, Alessia Liguori, Alessandro D'Aveni, Niki Karachaliou, Maria Gonzalez-Cao, Maria Grazia Daffinà, Chiara Lazzari, Giuseppe Altavilla, Rafael Rosell. J Thorac Dis 2018
51
18

Influence of molecular size and zeta potential in electrokinetic biosensing.
Siddharth Sourabh Sahu, Christiane Stiller, Sara Cavallaro, Amelie Eriksson Karlström, Jan Linnros, Apurba Dev. Biosens Bioelectron 2020
5
40

Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
Minsu Kang, Changhee Park, Se Hyun Kim, Sock Won Yoon, Koung Jin Suh, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim,[...]. Transl Lung Cancer Res 2021
3
66

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
18

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
Mark G Kris, Bruce E Johnson, Lynne D Berry, David J Kwiatkowski, A John Iafrate, Ignacio I Wistuba, Marileila Varella-Garcia, Wilbur A Franklin, Samuel L Aronson, Pei-Fang Su,[...]. JAMA 2014
981
18

Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.
Benqiang Rao, Yuanhong Gao, Jun Huang, Xiaoyan Gao, Xinhui Fu, Meijin Huang, Jiayin Yao, Jingping Wang, Wanglin Li, Junxiao Zhang,[...]. Int J Colorectal Dis 2011
31
9

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, Vicky Tagalakis, Sudeep Shivakumar, Ariah Schattner, Philip Kuruvilla, Danny Hill, Silvana Spadafora, Katerine Marquis,[...]. N Engl J Med 2019
304
9

Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.
Luis Corrales-Rodriguez, Denis Soulières, Xiaoduan Weng, Mustapha Tehfe, Marie Florescu, Normand Blais. Thromb Res 2014
22
9

Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.
Minh Phan, Sonia John, Ana I Casanegra, Suman Rathbun, Aaron Mansfield, Julie A Stoner, Alfonso J Tafur. J Thromb Thrombolysis 2014
26
9

Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation.
Sandra Regina, Jérôme Rollin, Claire Bléchet, Sophie Iochmann, Pascale Reverdiau, Yves Gruel. J Thorac Oncol 2008
42
9

The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism.
Jing Wang, Bin Hu, Tong Li, Jinbai Miao, Wenqian Zhang, Shuo Chen, Yixin Sun, Songping Cui, Hui Li. Ann Transl Med 2019
9
11


Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
Federico Nichetti, Francesca Ligorio, Emma Zattarin, Diego Signorelli, Arsela Prelaj, Claudia Proto, Giulia Galli, Antonio Marra, Giulia Apollonio, Luca Porcu,[...]. Cancers (Basel) 2019
17
9

Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study.
Chiara Alessandra Cella, Giovanni Di Minno, Chiara Carlomagno, Michele Arcopinto, Anna Maria Cerbone, Elide Matano, Antonella Tufano, Florian Lordick, Biagio De Simone, Katja Sibylle Muehlberg,[...]. Oncologist 2017
59
9

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Ramona Crescenzo, Francesco Abate, Elena Lasorsa, Fabrizio Tabbo', Marcello Gaudiano, Nicoletta Chiesa, Filomena Di Giacomo, Elisa Spaccarotella, Luigi Barbarossa, Elisabetta Ercole,[...]. Cancer Cell 2015
252
9

Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer.
A S Mansfield, A J Tafur, C E Wang, T V Kourelis, E M Wysokinska, P Yang. J Thromb Haemost 2016
77
9

Arterial thromboembolic events preceding the diagnosis of cancer in older persons.
Babak B Navi, Anne S Reiner, Hooman Kamel, Costantino Iadecola, Peter M Okin, Scott T Tagawa, Katherine S Panageas, Lisa M DeAngelis. Blood 2019
65
9


Tissue factor, thrombin, and cancer.
Frederick R Rickles, Steven Patierno, Patricia M Fernandez. Chest 2003
277
9

Prognosis of cancers associated with venous thromboembolism.
H T Sørensen, L Mellemkjaer, J H Olsen, J A Baron. N Engl J Med 2000
9

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
Alona Zer, Mor Moskovitz, David M Hwang, Anat Hershko-Klement, Ludmila Fridel, Grzegorz J Korpanty, Elizabeth Dudnik, Nir Peled, Tzippy Shochat, Natasha B Leighl,[...]. Clin Lung Cancer 2017
47
9

ALK is required for NLRP3 inflammasome activation in macrophages.
Bibo Zhang, Wei Wei, Jiaming Qiu. Biochem Biophys Res Commun 2018
13
9


RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.
Rui Wang, Haichuan Hu, Yunjian Pan, Yuan Li, Ting Ye, Chenguang Li, Xiaoyang Luo, Lei Wang, Hang Li, Yang Zhang,[...]. J Clin Oncol 2012
325
9

Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in NSCLC.
Hanny Al-Samkari, Orly Leiva, Ibiayi Dagogo-Jack, Alice Shaw, Jochen Lennerz, Anthony J Iafrate, Pavan K Bendapudi, Jean M Connors. J Thorac Oncol 2020
12
9

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).
Rita Chiari, Biagio Ricciuti, Lorenza Landi, Anna M Morelli, Angelo Delmonte, Gianluca Spitaleri, Diego L Cortinovis, Giuseppe Lamberti, Francesco Facchinetti, Sara Pilotto,[...]. Clin Lung Cancer 2020
24
9

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
9

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer.
Marliese Alexander, Nick Pavlakis, Thomas John, Rachel O'Connell, Steven Kao, Brett G M Hughes, Adrian Lee, Sarah A Hayes, Viive M Howell, Stephen J Clarke,[...]. Lung Cancer 2020
12
9

Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
Richard Li, Gretchen Hermann, Elizabeth Baldini, Aileen Chen, David Jackman, David Kozono, Paul Nguyen, Anju Nohria, Graham Powell, Raymond Mak. Lung Cancer 2016
10
10


Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients.
Orly Leiva, Jean M Connors, Hanny Al-Samkari. Cancers (Basel) 2020
11
9

Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma.
Seung Eun Lee, Boram Lee, Mineui Hong, Ji-Young Song, Kyungsoo Jung, Maruja E Lira, Mao Mao, Joungho Han, Jhingook Kim, Yoon-La Choi. Mod Pathol 2015
75
9

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer.
Atsuko Kitano, Makiko Ono, Masayuki Yoshida, Emi Noguchi, Akihiko Shimomura, Tatsunori Shimoi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu,[...]. ESMO Open 2017
61
9

Epidemiology of cancer-associated venous thrombosis.
Jasmijn F Timp, Sigrid K Braekkan, Henri H Versteeg, Suzanne C Cannegieter. Blood 2013
516
9

Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study.
Joanna Roopkumar, Shyam K Poudel, Lorenzo Gervaso, Chandana A Reddy, Vamsidhar Velcheti, Nathan A Pennell, Keith R McCrae, Alok A Khorana. J Thromb Haemost 2021
5
20

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
Jeanet W Blom, Carine J M Doggen, Susanne Osanto, Frits R Rosendaal. JAMA 2005
9

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.
Joanne L Yu, Linda May, Vladimir Lhotak, Siranoush Shahrzad, Senji Shirasawa, Jeffrey I Weitz, Brenda L Coomber, Nigel Mackman, Janusz W Rak. Blood 2005
404
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.